Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07424365 · ClinicalTrials.gov registry record · NA
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
A NA study of Parkinsons Disease (PD) and Mild Cognitive Impairment (MCI), sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07424365 is a NA study of Parkinsons Disease (PD) and Mild Cognitive Impairment (MCI) that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 80 participants, below the 115-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07424365, a NA study of Parkinsons Disease (PD) and Mild Cognitive Impairment (MCI), is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and other thinking abilities. This process, called transcutaneous auricular vagus nerve stimulation (taVNS), could help improve brain function in both healthy individuals and people with Parkinson's disease (PD).
Conditions Studied
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation
- DEVICE sham stimulation
Study Locations (1)
Colorado
- Clinical Translational Research Center at CU Anschutz - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2028-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07424365
The ClinicalTrials.gov registry entry for NCT07424365 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 115-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (30% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation is the first listed.
NCT07424365 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07424365 about?
NCT07424365 is a clinical study titled "Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations". This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and other thinking abilities. This process, called transcutaneous auricular vagus nerve stimulation (taVNS), could help improve b...
What is the current status of trial NCT07424365?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-19. Estimated completion is 2028-05.
What conditions does trial NCT07424365 study?
This clinical trial studies the following conditions: Parkinsons Disease (PD), Mild Cognitive Impairment (MCI), Healthy Adult.
What interventions are being tested in trial NCT07424365?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation (DEVICE), sham stimulation (DEVICE).
Who is sponsoring clinical trial NCT07424365?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07424365 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
RECRUITING · NA
-
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RECRUITING · NA
-
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
RECRUITING · NA
-
Electrophysiology-based DBS Programming for PD
RECRUITING · NA
-
A Study of NE3107 in Early Parkinson's
RECRUITING · Phase 2
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.